Veterinary Dermatology Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Veterinary Dermatology Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

  • Transparency Market Research
  • May 2021
  • Pharmaceutical
  • 184 pages

Report Description

Veterinary Dermatology Drugs Market – Scope of the Report

TMR’s report on the global veterinary dermatology drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global veterinary dermatology drugs market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global veterinary dermatology drugs market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global veterinary dermatology drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global veterinary dermatology drugs market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global veterinary dermatology drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary dermatology drugs market. The next section of the global veterinary dermatology drugs market report highlights the USPs, which include technological advancements, key industry events (mergers, acquisitions, strategic partnerships, etc.), top 3 players operating in the market, and COVID-19 pandemic impact on the global veterinary dermatology drugs market.

The report delves into the competitive landscape of the global veterinary dermatology drugs market. Key players operating in the global veterinary dermatology drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global veterinary dermatology drugs market report.

Key Questions Answered in Veterinary Dermatology Drugs Market Report

  • What are the sales/revenue generated by end users of veterinary dermatology drugs across all regions during the forecast period?
  • What are the key trends in the global veterinary dermatology drugs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2031 and which segment will expand at the highest CAGR during the forecast period?
  • Market rankings of different companies operating in the global market in 2020.

Veterinary Dermatology Drugs Market – Research Objectives and Research Approach

The comprehensive report on the global veterinary dermatology drugs market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global veterinary dermatology drugs market. It is followed by market introduction, market dynamics, and an overview of the global veterinary dermatology drugs market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global veterinary dermatology drugs market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key players has been mapped to ascertain the size of the global veterinary dermatology drugs market in terms of value. The forecast presented here assesses the total revenue generated in the global veterinary dermatology drugs market. In order to provide an accurate forecast, we initiated by sizing up the current veterinary dermatology drugs market with the help of the parent market.

The report analyzes the global veterinary dermatology drugs market in terms of product type, mode of administration, animal type, indication, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global veterinary dermatology drugs market.

Have query on this report?

Make an Enquiry

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Dermatology Drugs Market

4. Market Overview

4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Dermatology Drugs Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario by Region/globally
5.3. Cost of Veterinary Dermatological treatments 
5.4. List of Veterinary Dermatological Products Manufacturing Facilities, by Key Region 
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Product Type 
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
6.3.1. Antifungal Drugs
6.3.2. Antibacterial Drugs
6.3.3. Antiparasitic Drugs
6.3.4. Others
6.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type

7. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
7.3.1. Topical
7.3.2. Oral
7.3.3. Injectable
7.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration 

8. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Animal Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
8.3.1. Large Animals
8.3.1.1. Equine
8.3.1.2. Bovine
8.3.1.3. Others
8.3.2. Small Animals
8.3.2.1. Cat
8.3.2.2. Dogs
8.3.2.3. Others
8.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type

9. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
9.3.1. Infectious Diseases
9.3.2. Skin Cancer
9.3.3. Autoimmune Skin Diseases
9.3.4. Parasitic Infections
9.3.5. Others
9.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by  Indication

10. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Region 
10.1. Key Findings
10.2. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe 
10.2.3. Asia Pacific
10.2.4. Latin America 
10.2.5. Middle East & Africa
10.3. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region

11. North America Veterinary Dermatology Drugs Market Analysis and Forecast
11.1.  Introduction
11.1.1.  Key Findings
11.2. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
11.2.1. Antifungal Drugs
11.2.2. Antibacterial Drugs
11.2.3. Antiparasitic Drugs
11.2.4. Others
11.3. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
11.3.1. Oral
11.3.2. Topical
11.3.3. Injectable
11.4. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
11.4.1. Large Animals
11.4.1.1. Equine
11.4.1.2. Bovine
11.4.1.3. Others
11.4.2. Small Animals
11.4.2.1. Cat
11.4.2.2. Dogs
11.4.2.3. Others
11.5. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
11.5.1. Infectious Diseases
11.5.2. Skin Cancer
11.5.3. Autoimmune Skin Diseases
11.5.4. Parasitic Infections
11.5.5. Others
11.6. North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. North America Veterinary Dermatology Drugs Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Mode of Administration 
11.7.3. By Animal Type
11.7.4. By Indication
11.7.5. By Country

12. Europe Veterinary Dermatology Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1.  Key Findings
12.2. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
12.2.1. Antifungal Drugs
12.2.2. Antibacterial Drugs
12.2.3. Antiparasitic Drugs
12.2.4. Others
12.3. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
12.3.1. Oral
12.3.2. Topical
12.3.3. Injectable
12.4. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
12.4.1. Large Animals
12.4.1.1. Equine
12.4.1.2. Bovine
12.4.1.3. Others
12.4.2. Small Animals
12.4.2.1. Cat
12.4.2.2. Dogs
12.4.2.3. Others
12.5. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
12.5.1. Infectious Diseases
12.5.2. Skin Cancer
12.5.3. Autoimmune Skin Diseases
12.5.4. Parasitic Infections
12.5.5. Others
12.6. Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Veterinary Dermatology Drugs Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Mode of Administration 
12.7.3. By Animal Type
12.7.4. By Indication
12.7.5. By Country/Sub-region

13. Asia Pacific Veterinary Dermatology Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1.  Key Findings
13.2. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
13.2.1. Antifungal Drugs
13.2.2. Antibacterial Drugs
13.2.3. Antiparasitic Drugs
13.2.4. Others
13.3. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
13.3.1. Oral
13.3.2. Topical
13.3.3. Injectable
13.4. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
13.4.1. Large Animals
13.4.1.1. Equine
13.4.1.2. Bovine
13.4.1.3. Others
13.4.2. Small Animals
13.4.2.1. Cat
13.4.2.2. Dogs
13.4.2.3. Others
13.5. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
13.5.1. Infectious Diseases
13.5.2. Skin Cancer
13.5.3. Autoimmune Skin Diseases
13.5.4. Parasitic Infections
13.5.5. Others
13.6. Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India 
13.6.4. Australia & New Zealand 
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Veterinary Dermatology Drugs Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Mode of Administration 
13.7.3. By Animal Type
13.7.4. By Indication
13.7.5. By Country/Sub-region

14. Latin America Veterinary Dermatology Drugs Market Analysis and Forecast
14.1. Introduction
14.1.1.  Key Findings
14.2. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
14.2.1. Antifungal Drugs
14.2.2. Antibacterial Drugs
14.2.3. Antiparasitic Drugs
14.2.4. Others
14.3. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
14.3.1. Oral
14.3.2. Topical
14.3.3. Injectable
14.4. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
14.4.1. Large Animals
14.4.1.1. Equine
14.4.1.2. Bovine
14.4.1.3. Others
14.4.2. Small Animals
14.4.2.1. Cat
14.4.2.2. Dogs
14.4.2.3. Others
14.5. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
14.5.1. Infectious Diseases
14.5.2. Skin Cancer
14.5.3. Autoimmune Skin Diseases
14.5.4. Parasitic Infections
14.5.5. Others
14.6. Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Veterinary Dermatology Drugs Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Mode of Administration 
14.7.3. By Animal Type
14.7.4. By Indication
14.7.5. By Country/Sub-region

15. Middle East & Africa Veterinary Dermatology Drugs Market Analysis and Forecast
15.1. Introduction
15.1.1.  Key Findings
15.2. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
15.2.1. Antifungal Drugs
15.2.2. Antibacterial Drugs
15.2.3. Antiparasitic Drugs
15.2.4. Others
15.3. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
15.3.1. Oral
15.3.2. Topical
15.3.3. Injectable
15.4. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
15.4.1. Large Animals
15.4.1.1. Equine
15.4.1.2. Bovine
15.4.1.3. Others
15.4.2. Small Animals
15.4.2.1. Cat
15.4.2.2. Dogs
15.4.2.3. Others
15.5. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
15.5.1. Infectious Diseases
15.5.2. Skin Cancer
15.5.3. Autoimmune Skin Diseases
15.5.4. Parasitic Infections
15.5.5. Others
15.6. Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries 
15.6.2. South Africa 
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Veterinary Dermatology Drugs Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Mode of Administration 
15.7.3. By Animal Type
15.7.4. By Indication
15.7.5. By Country/Sub-region

16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Bayer
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Bimeda, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Boehringer Ingelheim GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Ceva Santé Animale
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Eli Lilly and Company
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Merck Animal Health
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Sanofi S.A.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Virbac
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Zoetis, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis

List of Tables

Table 01: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 03: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 04: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 05: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 06: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 08: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 10: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 11: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 12: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 13: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 14: North America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 17: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 18: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 19: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 20: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 21: Europe Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 22: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 23: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 24: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 25: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 26: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 27: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 28: Asia Pacific Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 29: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 30: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 31: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 32: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 33: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 34: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 35: Latin America Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 36: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 37: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 38: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017–2031
Table 39: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 40: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Large Animal Type, 2017–2031
Table 41: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Small Animal Type, 2017–2031
Table 42: Middle East & Africa Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017–2031

Success Stories

Our Clients